State Street SPDR S&P Biotech ETF vs Yum China Holdings Inc — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.5, while Yum China Holdings Inc trades at $43.91 (market cap $15.09B). The key difference: Yum China Holdings Inc pays a 2.64% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Yum China Holdings Inc nearer its low. Which is the better fit depends on your goals.
| XBI | YUMC | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Cyclical |
52-Week High | $164.28 | $57.95 |
52-Week Low | $85.16 | $40.18 |
Market Cap | — | $15.09B |
Enterprise Value | — | $15.98B |
Dividend Yield | — | 2.64% |
Trailing returns across standard periods
Latest headlines on both assets
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →